RESUMEN
Within and surrounding high-latitude cities, poor air quality disturbs Arctic ecosystems, influences the climate, and harms human health. The Fairbanks North Star Borough has wintertime particulate matter (PM) concentrations that exceed the Environmental Protection Agency's (EPA) threshold for public health. Particulate sulfate (SO4 2-) is the most abundant inorganic species and contributes approximately 20% of the total PM mass in Fairbanks, but air quality models underestimate observed sulfate concentrations. Here we quantify sulfate sources using size-resolved δ34S(SO4 2-), δ18O(SO4 2-), and Δ17O(SO4 2-) of particulate sulfate in Fairbanks from January 18th to February 25th, 2022 using a Bayesian isotope mixing model. Primary sulfate contributes 62 ± 12% of the total sulfate mass on average. Most primary sulfate is found in the size bin with a particle diameter < 0.7 µm, which contains 90 ±5% of total sulfate mass and poses the greatest risk to human health. Oxidation by all secondary formation pathways combined contributes 38 ± 12% of total sulfate mass on average, indicating that secondary sulfate formation is inefficient in this cold, dark environment. On average, the dominant secondary sulfate formation pathways are oxidation by H2O2 (13 ± 6%), O3 (8 ± 4%), and NO2 (8 ± 3%). These findings will inform mitigation strategies to improve air quality and public health in Fairbanks and possibly other high-latitude urban areas during winter.
RESUMEN
BACKGROUND: One of the defining narratives of the COVID-19 pandemic has been the acceptance and distribution of vaccine. To compare the outcomes of COVID-19 positive vaccinated and unvaccinated stroke patients. METHODS: This is a single-center retrospective study of COVID-19-vaccinated and unvaccinated stroke patients between April 2020 and March 2022. All patients presenting with stroke regardless of treatment modalities were included. National Institutes of Health Stroke Scale was used to assess stroke severity. The primary outcome was functional capacity of the patients at discharge. RESULTS: The study cohort comprised 203 COVID-19 positive stroke patients divided into 139 unvaccinated and 64 fully vaccinated patients. At discharge, the modified Rankin scale score was significantly lower in the vaccinated cohort (3[1-4] vs. 4[2-5], odds ratio = 0.508, P = 0.011). At 3 months of follow-up, the median modified Rankin scale score was comparable between both cohorts. CONCLUSIONS: Although vaccination did not show any significant difference in stroke patient outcomes on follow-up, vaccines were associated with lower rates of morbidity and mortality at discharge among stroke patients during the pandemic.